SynOx Joins Wave of Biotechs Attacking Solid Tumor ‘Comfort Zone’
Labiotech.eu,
The newly founded SynOx has become the latest startup to attack solid tumors via their ‘comfort zone’, known as the tumor…
The newly founded SynOx has become the latest startup to attack solid tumors via their ‘comfort zone’, known as the tumor…
The recent founding of Modulus Therapeutics in the UK has highlighted an accelerating movement in cancer research that aims to…